Prostate Mapping is a modern prostate biopsy method
Prostate Mapping: man smiling after template prostate biopsy with MRI
Logo Prostate Mapping biopsy
Prostate mapping homeProstate biopsy and current diagnosisNew prostate mapping biopsy diagnosisCases of prostate mapping biopsyTreatment optionsAbout the prostate mapping teamContactsProstate mapping

About us

Prostate Mapping Ltd. is the fruit of collaboration between some of the world's leading urology surgeons, anaesthetists and specialist uro-radiologists making this unique prostate mapping service available to men from a leading London Hospital.

Prof Mark Emberton MD FRCS Urol
Professor of Interventional Oncology, UCL
Honorary Consultant Urological Surgeon UCH NHS Trust



Prof Mark Emberton MD FRCS Urol<br/>Professor of Interventional Oncology, UCL<br/>Honorary Consultant Urological Surgeon UCH NHS Trust
Mark Emberton holds the post of Professor in Interventional Oncology at University College London and is Associate Professor at Middlesex University, London. At UCLH he is Pathway Director for Urological Cancer for UCL Partners. He is also Honorary Clinical Director of the Clinical Effectiveness Unit at the Royal College of Surgeons of England. His clinical and research interests are focused mainly on diseases of the prostate gland, both benign and malignant. Much of his activity is at present focused on evaluating minimally invasive therapies for localised prostate cancer. This work encompasses the fields of precise characterisation of disease as well as targeting therapies. A current interest includes the non invasive evaluation of men at risk of having prostate cancer. He is an active researcher, lectures widely and has published over 100 peer reviewed publications as well as numerous books and chapters.